Braden score may be associated with time to onset of catheter-associated urinary tract infection in high-risk patients: Lessons learned from a root cause analysis tool

2019 ◽  
Vol 47 (3) ◽  
pp. 343-345
Author(s):  
Beverly Sturgill ◽  
Harsh Patolia ◽  
Alexis Gushiken ◽  
Mariana Gomez dela Espriella ◽  
Anthony W. Baffoe-Bonnie
2016 ◽  
Vol 72 (2) ◽  
pp. 522-528 ◽  
Author(s):  
Christopher Staley ◽  
Byron P. Vaughn ◽  
Carolyn T. Graiziger ◽  
Michael J. Sadowsky ◽  
Alexander Khoruts

2015 ◽  
Vol 7 (19) ◽  
pp. 7961-7975 ◽  
Author(s):  
H. Karlsen ◽  
T. Dong

Supplementary urinary tract infection biomarkers might help to improve the performance and reliability of urine test strips for high risk groups.


2018 ◽  
Vol 10 (10) ◽  
pp. 283-293 ◽  
Author(s):  
Ivy Y. Ge ◽  
Helene B. Fevrier ◽  
Carol Conell ◽  
Malika N. Kheraj ◽  
Alexander C. Flint ◽  
...  

Background: Risk of community-acquired Clostridium difficile infection (CA-CDI) following antibiotic treatment specifically for urinary tract infection (UTI) has not been evaluated. Methods: We conducted a nested case-control study at Kaiser Permanente Northern California, 2007–2010, to assess antibiotic prescribing and other factors in relation to risk of CA-CDI in outpatients with uncomplicated UTI. Cases were diagnosed with CA-CDI within 90 days of antibiotic use. We used matched controls and confirmed case-control eligibility through chart review. Antibiotics were classified as ciprofloxacin (most common), or low risk (nitrofurantoin, sulfamethoxazole/trimethoprim), moderate risk, or high risk (e.g. cefpodoxime, ceftriaxone, clindamycin) for CDI. We computed the adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the relationship of antibiotic treatment for uncomplicated UTI and history of relevant gastrointestinal comorbidity (including gastrointestinal diagnoses, procedures, and gastric acid suppression treatment) with risk of CA-CDI using logistic regression analysis. Results: Despite the large population, only 68 cases were confirmed with CA-CDI for comparison with 112 controls. Female sex [81% of controls, adjusted odds ratio (OR) 6.3, CI 1.7–24), past gastrointestinal comorbidity (prevalence 39%, OR 2.3, CI 1.1–4.8), and nongastrointestinal comorbidity (prevalence 6%, OR 2.8, CI 1.4–5.6) were associated with increased CA-CDI risk. Compared with low-risk antibiotic, the adjusted ORs for antibiotic groups were as follows: ciprofloxacin, 2.7 (CI 1.0–7.2); moderate-risk antibiotics, 3.6 (CI 1.2–11); and high-risk antibiotics, 11.2 (CI 2.4–52). Conclusions: Lower-risk antibiotics should be used for UTI whenever possible, particularly in patients with a gastrointestinal comorbidity. However, UTI can be managed through alternative approaches. Research into the primary prevention of UTI is urgently needed.


Author(s):  
Erica Freire de Vasconcelos-Pereira ◽  
Ernesto Antonio Figueiró-Filho ◽  
Vanessa Marcon de Oliveira ◽  
Ana Cláudia Oliveira Fernandes ◽  
Clícia Santos de Moura Fé ◽  
...  

2017 ◽  
Vol 50 (4) ◽  
pp. 464-470 ◽  
Author(s):  
Chih-Cheng Lai ◽  
Chun-Ming Lee ◽  
Hsiu-Tzy Chiang ◽  
Ching-Tzu Hung ◽  
Ying-Chun Chen ◽  
...  

2013 ◽  
Vol 34 (10) ◽  
pp. 1048-1054 ◽  
Author(s):  
Mohamad G. Fakih ◽  
Christine George ◽  
Barbara S. Edson ◽  
Christine A. Goeschel ◽  
Sanjay Saint

Catheter-associated urinary tract infection (CAUTI) represents a significant proportion of healthcare-associated infections (HAIs). The US Department of Health and Human Services issued a plan to reduce HAIs with a target 25% reduction of CAUTI by 2013. Michigan's successful collaborative to reduce unnecessary use of urinary catheters and CAUTI was based on a partnership between diverse hospitals, the state hospital association (SHA), and academic medical centers. Taking the lessons learned from Michigan, we are now spreading this work throughout the 50 states. This national spread leverages the expertise of different groups and organizations for the unified goal of reducing catheter-related harm. The key components of the project are (1) centralized coordination of the effort and dissemination of information to SHAs and hospitals, (2) data collection based on established definitions and approaches, (3) focused guidance on the technical practices that will prevent CAUTI, (4) emphasis on understanding the socioadaptive aspects (both the general, unit-wide issues and CAUTI-specific challenges), and (5) partnering with specialty organizations and governmental agencies who have expertise in the relevant subject area. The work may serve in the future as a model for other large improvement efforts to address other hospital-acquired conditions, such as venous thromboembolism and falls.


Sign in / Sign up

Export Citation Format

Share Document